JPRN-UMIN000005900招募中2 期
Phase II study of combination chemotherapy with TS-1/irinotecan and bevacizumab as second-line therapy in patient with K-RAS mutation-type metastatic colorectal cancer - SRIM study
PO FMPC (Future Medicine Promoting Consortium)0 个研究点目标入组 40 人开始时间: 2011年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) History of serious drug hypersensitivity (2) Women who are pregnant,lactating,or wish to become pregnant or men who expect babies. (3) Severe infectious disease (4) Serious complications (5) Clinically significant heart disease (6) Gastrointestinal ulceration or bleeding (7) Watery diarrhea (8) Uncontrolable pleural effusion or ascites requiring (9) Symptomatic brain metastases (10) Current or previous (within the last 6months) history of GI perforation (11) Previous history of thrombosis,cerebral infarction,pulmonary infarction,hemoptysis and interstitial pneumonia (12) were operated within 28days before entry (13) Evidence of bleeding diathesis or coagulopathy (14) ongoing treatment with anticoagulant (15) had active double cancer (16) Systemic administration of corticosteroids (17) Patients judged inappropriate for this study by physicians
研究者
相似试验
未知
1 期
A Phase I Study of Concurrent Chemotherapy using TS-1 with Involved Field Radiotherapy for Elderly Patients with Non-Small Cell Lung Cancer.on-Small Cell Lung CancerJPRN-UMIN000002162Hiroshima Radiation Oncology Study Group18
招募中
2 期
Phase II study of combination chemotherapy with S-1 plus Avastin in unresectable or recurrent colorectal cancer after failure of prior chemotherapy, including irinotecan and oxaliplatin regimens.colorectal cancerJPRN-UMIN000002308Translational Research Informatics Center(TRI)40
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced lung squamous cell carcinomaung cancerJPRN-UMIN000006983Hamamatsu University School of Medicine50
已完成
2 期
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancernon-small-cell lung cancerJPRN-UMIN000010189ational Hospital Organization Osaka20
已完成
2 期
A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.advanced or recurrent gastric cancerJPRN-UMIN000008220Osaka medical center for cancer and cardiovascular diseases20